Clinical Study
The Antibiotic Resistance Profiles of Bacterial Strains Isolated from Patients with Hospital-Acquired Bloodstream and Urinary Tract Infections
Table 1
Antimicrobial resistance profiles of hospital-acquired bacterial isolates from clinical blood specimens.
| | Antimicrobial agents | Microorganisms | Total
n (%)
| CoNS*
n (%) | .
n (%) | .
n (%) | Aceinetobacter
spp.n (%) |
spp.
n (%) | .
n (%) | .
n (%) |
| | Ciprofloxacin | 22 (48.9) | 18 (47.4) | 6 (42.9) | 5 (45.5) | 1 (11.1) | 2 (40) | 2 (40) | 56 (43.4) | | Ceftazidime | 18 (40) | 15 (39.5) | 6 (42.9) | 6 (54.5) | 3 (33.3) | 3 (60) | 3 (60) | 54 (41.9) | | Amikacin | 20 (44.4) | 6 (15.8) | 6 (42.9) | 6 (54.5) | 0 (0) | 3 (60) | 3 (60) | 44 (34.1) | | Imipenem | 16 (35.6) | 6 (15.8) | 6 (42.9) | 6 (54.5) | 2 (22.2) | 4 (80) | 4 (80) | 44 (34.1) | | Clindamycin | 28 (62.2) | 19 (50) | 6 (42.9) | 6 (54.5) | 2 (22.2) | 3 (60) | 4 (80) | 68 (52.7) | | Vancomycin | 2 (4.4) | NA* | NA | NA | NA | 0 (0) | NA | 2 (1.6) | | Cephalothin | 22 (48.9) | 16 (42.1) | 9 (64.3) | 9 (81.8) | 3 (33.3) | 2 (40) | 3 (60) | 64 (49.6) | | Ampicillin | 34 (75.6) | 24 (63.2) | 7 (50) | 7 (63.6) | 4 (44.4) | 5 (100) | 5 (100) | 86 (66.7) | | Cotrimoxazole | 26 (57.8) | 19 (50) | 12 (85.7) | 7 (63.6) | 1 (11.1) | 5 (100) | 5 (100) | 75 (58.1) | | Cefoxitin | 26 (57.8) | 17 (44.7) | 8 (47.1) | 6 (54.5) | 2 (22.2) | 4 (80) | 4 (80) | 67 (51.9) | | Oxacillin | 28 (62.2) | NA | NA | NA | NA | 2 (40) | NA | 30 (23.3) | | Erythromycin | 17 (37.8) | 13 (34.2) | 6 (42.9) | 4 (36.4) | 1 (11.1) | 3 (60) | 4 (80) | 48 (37.2) | | Tetracycline | 23 (51.1) | 24 (63.2) | 9 (64.3) | 5 (45.5) | 6 (66.6) | 4 (80) | 5 (100) | 76 (58.9) | | Penicillin | 41 (91.1) | 22 (58) | 11 (78.6) | 7 (63.6) | 4 (44.4) | 5 (100) | 5 (100) | 95 (73.6) | | Gentamicin | 16 (35.6) | 6 (15.8) | 4 (28.6) | 7 (63.6) | 2 (22.2) | 4 (80) | 2 (40) | 41 (31.8) |
| | Total | 45 (34.8) | 38 (29.4) | 14 (11) | 11 (8.5) | 9 (7) | 5 (3.9) | 5 (3.9) | 127 (98.5) |
|
|
CoNS*: Coagulase-negative Staphylococci.
NA*: Not applicable.
|
